You would like to apply for “orphan designation” (ODD) in the EU to receive incentives for developing orphan drugs and notice that ODD must be held by a legal entity based in the EU?
Our solution:
Highly experienced regulatory experts will provide you or your contracted local CROs with competent, quick and cost-efficient sponsor representation services enabling application for ODD in the EU.
How does it work?
Book a free consultation with our Regulatory Affairs experts.
Get all the information needed regarding orphan drug designation in your target market.
Set up a contract with us to be Orphan Medicinal Product Regulation (EC) No141/2000 compliant.
Benefit from the incentives of orphan drug designation in Europe.
We may also support you with getting a SME status in the EU.
professional regulatory experts, each having 10+ years of experience
Book your free consultation now:
Angela Denzel
Director Representative Affairs
Your successful clinical development is our goal. You can rely on our expertise. The familiarity of FGK`s team in a frequently changing regulatory environment is an excellent basis for a long-term partnership.